Merz, Shionogi sales and marketing update

Merz's Merz Inc. affiliate acquired U.S. rights to Shionogi's Cuvposa glycopyrrolate oral solution. The anti-cholinergic agent is approved in the U.S. to reduce chronic severe drooling resulting from...